Global Webinar Series
Sleep Quality and Medical Cannabis - An International Roundtable
In collaboration with The Sapphire Institute for Medical Cannabis Education.
As research into the medicinal and therapeutic potential of cannabis continues to pick up the pace, a growing number of people across the world report using cannabis-based medicines to aid sleep. Sleep quality is an important aspect of a health life; however, research consistently shows that a significant proportion of the population suffers from poor sleep and sleep conditions such as insomnia.
Global experts will review the existing evidence for the potential of medical cannabis and cannabinoids in the treatment of impaired sleep, including randomised controlled trials, as well as sharing the latest research projects, trials and patient outcomes.
Meet The Speakers:
Dr Jen Walsh
Lecturer at the Centre for Sleep Science in the School of Human Sciences at The University of Western Australia and a research fellow at the West Australian Sleep Disorders Research Institute. She recently published the results of the ZTL-INS-201, a trial investigating medical cannabis in insomnia.
Professor Ron Grunstein
Professor of Sleep Medicine at the University of Sydney and lead of the Sleep and Circadian Research Group at the Woolcock Institute. He is the principle investigator on the CANSLEEP trial.
Dr Mark Weatherall
Consultant Neurologist at Sapphire Medical Clinics prescribing medical cannabis for a range of neurological conditions including treatment resistant insomnia.